About Jamrex Biotech
Jamrex Biotech is a Healthcare company. Pharmaceutical manufacturing and distribution of formulations in healthcare. Its Indian entity Jamrex Biotech Private Limited reported revenue of ₹3.80 Cr. Jamrex Biotech offers products and services including Generic Formulations and Custom Formulation. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic and Branded Formulations and Medical Supplies.
Company details
High-quality pharmaceutical solutions are provided by Jamrex Biotech, focusing on innovation and compliance with international standards. A wide range of medicines for therapeutic areas such as gastro, cardiac, diabetic care, and neurology is delivered through WHO-GMP certified manufacturing. Products are exported globally with necessary certifications, while custom formulations and packaging are developed for partners. Reliable formulations backed by clinical research are emphasized, ensuring safety and effective health outcomes across India and beyond, with a commitment to ethical practices and continual improvement.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website jamrexbiotech.com
- Social Facebook
- Legal Name Jamrex Biotech Pvt. Ltd
- Date of Incorporation 05 Dec, 2018
- Jurisdiction Lucknow, Uttar Pradesh, India
- Indian entity revenue₹3.80 Cr
FY 2025 · +47% YoY
- Indian entity net profit₹11.3 Lakh
FY 2025 · 3% margin
- Indian entity EBITDA₹23.1 Lakh
FY 2025 · 6% margin
Associated legal entities of Jamrex Biotech
Jamrex Biotech operates through Jamrex Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jamrex Biotech Private Limited CIN U85190UP2018PTC110916 | Active | 05 Dec 2018 | Lucknow, Uttar Pradesh | ₹3.8 Cr | 3 | View details |
Products & Services of Jamrex Biotech
Jamrex Biotech offers a comprehensive portfolio of products and services, including Generic Formulations and Custom Formulation.
Reliable generic and branded medicines are manufactured for key therapeutic areas like gastro and cardiac care.
Exclusive combinations and packaging solutions are developed for targeted markets and partners.
Board of directors of Jamrex Biotech Private Limited (Jamrex Biotech)
Jamrex Biotech Private Limited is the primary company behind Jamrex Biotech. The board of Jamrex Biotech Private Limited currently have 3 directors; the longest-serving is Mohd Atahafeez, appointed in 2018. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mohd Atahafeez DIN 08295326 | Director | 05 Dec 2018 | 7 yrs 11 mo | Jamrex Biotech Private Limited |
| Ravindra Pratap Singh DIN 08295325 | Director | 05 Dec 2018 | 7 yrs 11 mo | Jamrex Biotech Private Limited |
| Mohammad Anzar DIN 07601621 | Director | 04 Jun 2025 | 1 yr 5 mo | Jamrex Biotech Private Limited |
Financials of Jamrex Biotech
Figures of Jamrex Biotech Private Limited, the primary company behind Jamrex Biotech, for FY 2025. Revenue was ₹3.80 Cr (+47% year on year). Net profit was ₹11.3 Lakh (3% margin). EBITDA was ₹23.1 Lakh (6% margin). Revenue has grown at a compounded annual rate of +23% over three years and +27% over five years.
- ₹3.80 CrRevenue · FY 2025 · +47% YoY
- ₹11.3 LakhNet profit · 3% margin
- ₹23.1 LakhEBITDA · 6% margin
- ₹1 LakhPaid-up capital
- +23%Revenue CAGR, 3 years
- +27%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Jamrex Biotech Private Limited are on its company page.
Detailed financial statements for Jamrex Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Jamrex Biotech
The primary company behind Jamrex Biotech, Jamrex Biotech Private Limited, reported revenue of ₹3.80 Cr for FY 2025, up 47% year on year.
High-quality pharmaceutical solutions are provided by Jamrex Biotech, focusing on innovation and compliance with international standards. A wide range of medicines for therapeutic areas such as gastro, cardiac, diabetic care, and neurology is delivered through WHO-GMP certified manufacturing. Products are exported globally with necessary certifications, while custom formulations and packaging are developed for partners. Reliable formulations backed by clinical research are emphasized, ensuring safety and effective health outcomes across India and beyond, with a commitment to ethical practices and continual improvement.
Jamrex Biotech offers Generic Formulations and Custom Formulation.
Jamrex Biotech operates through Jamrex Biotech Private Limited.
The legal entities of Jamrex Biotech currently have 3 directors, including Mohd Atahafeez, Mohammad Anzar, Ravindra Pratap Singh.